d-alpha tocopherol has been researched along with Psychoses in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (19.05) | 18.7374 |
| 1990's | 4 (19.05) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amminger, GP; Berk, M; Hesse, J; Hipler, UC; Holub, M; Holzer, I; Klier, CM; McGorry, PD; Milleit, B; Milleit, C; Sauer, H; Schaefer, MR; Smesny, S; Wiegand, C | 1 |
| Bergman, H; Maayan, N; Soares-Weiser, K | 1 |
| Amminger, GP; Bechdolf, A; Chanen, AM; Klier, CM; McGorry, PD; Mossaheb, N; Nelson, B; Ohmann, S; Schäfer, MR; Thompson, A; Yung, AR | 1 |
| Abdulla, A; Kaklotar, D; Muthu, MS; Pandey, BL; Rajesh, CV; Sahu, AK; Singh, S | 1 |
| Amminger, GP; Berk, M; Kim, SW; Klier, CM; McGorry, PD; McNamara, RK; Mechelli, A; Rice, S; Schäfer, MR | 1 |
| Acikgoz, HE; Akkaya, C; Dirican, M; Eker, SS; Sarandol, A; Sarandol, E | 1 |
| MICHAEL, ST; RUGGLES, AH | 1 |
| Maayan, N; McGrath, J; Soares-Weiser, K | 1 |
| Eriksen, SA | 1 |
| Peskin, ER; Pfeiffer, EA; Porsteinsson, AP; Schneider, LS | 1 |
| LEITNER, ZA; MOORE, T; SHARMAN, IM | 1 |
| Kotsirilos, V | 1 |
| Brown, D; Factor, SA; Molho, ES; Podskalny, GD | 1 |
| Dorevitch, A; Kalian, M; Lerner, V; Shlafman, M | 1 |
| Devarajan, S; Dursun, SM; Kutcher, SP; Oluboka, OJ | 1 |
| McGrath, JJ; Soares, KV | 2 |
| Bridler, R | 1 |
| Seitz, H | 1 |
| Bacher, N; Barrett, D; Elkashef, AM; Ruskin, PE | 1 |
| Hornstein, OP | 1 |
6 review(s) available for d-alpha tocopherol and Psychoses
| Article | Year |
|---|---|
Vitamin E for antipsychotic-induced tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Disease Progression; Dyskinesia, Drug-Induced; Humans; Patient Acceptance of Health Care; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E; Vitamins | 2018 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E; Vitamins | 2011 |
Choosing treatment for Alzheimer's patients and their caregivers.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticonvulsants; Antipsychotic Agents; Caregivers; Cholinesterase Inhibitors; Depression; Ginkgo biloba; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phytotherapy; Plant Extracts; Professional-Family Relations; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Risk Factors; Social Support; Vitamin E | 2003 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Schizophrenia; Vitamin E | 2000 |
Vitamin E for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Vitamin E | 2001 |
[Treatment of various important fertility disorders in male patients].
Topics: Androgens; Anti-Bacterial Agents; Dietary Proteins; Humans; Infertility, Male; Insemination, Artificial; Male; Parasympatholytics; Protein Deficiency; Psychotic Disorders; Spermatozoa; Vitamin E; Vitamin E Deficiency; Vitamins | 1971 |
6 trial(s) available for d-alpha tocopherol and Psychoses
| Article | Year |
|---|---|
Omega-3 fatty acid supplementation in adolescents with borderline personality disorder and ultra-high risk criteria for psychosis: a post hoc subgroup analysis of a double-blind, randomized controlled trial.
Topics: Adolescent; Borderline Personality Disorder; Coconut Oil; Docosahexaenoic Acids; Drug Combinations; Eicosapentaenoic Acid; Fatty Acids, Omega-3; Female; Humans; Male; Placebos; Plant Oils; Psychiatric Status Rating Scales; Psychotic Disorders; Risk; Treatment Outcome; Vitamin E; Vitamins | 2013 |
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.
Topics: Adolescent; Adult; alpha-Linolenic Acid; Arachidonic Acid; Docosahexaenoic Acids; Double-Blind Method; Eicosapentaenoic Acid; Erythrocyte Membrane; Fatty Acids; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Female; Humans; Linear Models; Linoleic Acid; Male; Multivariate Analysis; Psychotic Disorders; Risk; Treatment Outcome; Vitamin E; Vitamins; Young Adult | 2015 |
Treatment of long-term tardive dyskinesia with vitamin E.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neurologic Examination; Psychotic Disorders; Schizophrenia; Vitamin E | 1997 |
[Vitamin E is ineffective in treatment of late dyskinesias].
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Neurologic Examination; Psychotic Disorders; Treatment Failure; Vitamin E | 2001 |
[Experiences with Juston in patients with depressive and dystonic disorders].
Topics: Antidepressive Agents; Ascorbic Acid; Clinical Trials as Topic; Depression; Drug Combinations; Drug Evaluation; Humans; Magnesium; Middle Aged; Psychotic Disorders; Vitamin A; Vitamin B Complex; Vitamin E; Xanthines | 1976 |
Vitamin E in the treatment of tardive dyskinesia.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Placebos; Psychotic Disorders; Randomized Controlled Trials as Topic; Vitamin E | 1990 |
9 other study(ies) available for d-alpha tocopherol and Psychoses
| Article | Year |
|---|---|
Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis.
Topics: Adolescent; Adult; alpha-Tocopherol; Antioxidants; Cross-Sectional Studies; Fatty Acids; Fatty Acids, Omega-3; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; Psychotic Disorders; Treatment Outcome; Vitamin E; Young Adult | 2015 |
Solubilized delivery of paliperidone palmitate by D-alpha-tocopheryl polyethylene glycol 1000 succinate micelles for improved short-term psychotic management.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Chemistry, Pharmaceutical; Drug Compounding; Drug Delivery Systems; Mice; Micelles; Paliperidone Palmitate; Particle Size; Polyethylene Glycols; Psychotic Disorders; Vitamin E | 2016 |
First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment.
Topics: Adult; Antipsychotic Agents; Apolipoprotein B-100; Aryldialkylphosphatase; Bilirubin; Carboxylic Ester Hydrolases; Case-Control Studies; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; Serum Albumin; Serum Albumin, Human; Superoxide Dismutase; Uric Acid; Vitamin E; Young Adult | 2015 |
Vitamin E in treatment of mental disorders.
Topics: Humans; Mental Disorders; Psychotic Disorders; Vitamin E | 1947 |
[Do fish fats and vitamins have any effect in psychoses?].
Topics: Dietary Fats; Fatty Acids, Omega-3; Humans; Psychotic Disorders; Schizophrenia; Vitamin E | 2003 |
VITAMIN A AND VITAMIN E IN HUMAN BLOOD. 3. LEVELS IN PATIENTS IN PSYCHIATRIC HOSPITALS.
Topics: Blood Chemical Analysis; Carotenoids; Chromatography; Dementia; Hospitals, Psychiatric; Humans; Hysteria; Intellectual Disability; Mental Disorders; Neurotic Disorders; Obsessive-Compulsive Disorder; Paranoid Disorders; Psychotic Disorders; Schizophrenia; Vitamin A; Vitamin E | 1964 |
Psychotic illness--does complementary medicine have a role in management?
Topics: Antipsychotic Agents; Complementary Therapies; Drugs, Chinese Herbal; Dyskinesia, Drug-Induced; Fatty Acids, Unsaturated; Humans; Music Therapy; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Vitamin E | 2006 |
The effect of dancing on dystonia.
Topics: Adult; Antipsychotic Agents; Bromocriptine; Clozapine; Dancing; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Psychotic Disorders; Trihexyphenidyl; Vitamin E | 1996 |
High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome.
Topics: Aged; Antipsychotic Agents; Drug Therapy, Combination; Female; Humans; Neuroleptic Malignant Syndrome; Neurologic Examination; Psychiatric Status Rating Scales; Psychotic Disorders; Pyridoxine; Risperidone; Vitamin E | 1998 |